These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39273393)

  • 1. Digital Whole Slide Image Analysis of Elevated Stromal Content and Extracellular Matrix Protein Expression Predicts Adverse Prognosis in Triple-Negative Breast Cancer.
    Karancsi Z; Gregus B; Krenács T; Cserni G; Nagy Á; Szőcs-Trinfa KF; Kulka J; Tőkés AM
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients.
    Gole L; Yeong J; Lim JCT; Ong KH; Han H; Thike AA; Poh YC; Yee S; Iqbal J; Hong W; Lee B; Yu W; Tan PH
    Breast Cancer Res; 2020 May; 22(1):42. PubMed ID: 32375854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased number of intratumoral IL-17+ cells, a harbinger of the adverse prognosis of triple-negative breast cancer.
    Qian XL; Xu P; Zhang YQ; Song YM; Li YQ; Li WD; Jiang CY; Shen BB; Zhang XM; Zhang LN; Fu L; Guo XJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):311-319. PubMed ID: 31993861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal Type I Collagen in Breast Cancer: Correlation to Prognostic Biomarkers and Prediction of Chemotherapy Response.
    Jansson M; Lindberg J; Rask G; Svensson J; Billing O; Nazemroaya A; Berglund A; Wärnberg F; Sund M
    Clin Breast Cancer; 2024 Jul; 24(5):e360-e369.e4. PubMed ID: 38485557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal CD73 Expression in Breast Cancer: Subtype-specific Expression and its Prognostic Significance.
    Tanaka M; Aoki M; Masuda Y; Yoshinaga Y; Hamasaki M; Iwasaki A; Sato T
    Anticancer Res; 2024 Aug; 44(8):3637-3643. PubMed ID: 39060073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
    Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Santos J; García P; Massó J; Bellosillo B; Lloveras B; Albanell J; Vázquez I; Comerma L
    Virchows Arch; 2023 Nov; 483(5):655-663. PubMed ID: 37500796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
    Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE
    Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
    Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
    BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer.
    Millar EK; Browne LH; Beretov J; Lee K; Lynch J; Swarbrick A; Graham PH
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33322174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal PD-L1 Expression Is Associated With Better Disease-Free Survival in Triple-Negative Breast Cancer.
    Li X; Wetherilt CS; Krishnamurti U; Yang J; Ma Y; Styblo TM; Meisel JL; Peng L; Siddiqui MT; Cohen C; Aneja R
    Am J Clin Pathol; 2016 Oct; 146(4):496-502. PubMed ID: 27686176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer.
    Zheng HM; Chen C; Wu XH; Chen J; Sun S; Sun JZ; Wang MW; Sun SR
    Tumour Biol; 2016 Feb; 37(2):2509-18. PubMed ID: 26385773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical Profile of Triple-Negative Breast Cancers: SOX10 and AR Dual Negative Tumors Have Worse Outcomes.
    Rammal R; Goel K; Motanagh SA; Carter GJ; Clark BZ; Fine JL; Harinath L; Villatoro TM; Yu J; Bhargava R
    Mod Pathol; 2024 Jul; 37(7):100517. PubMed ID: 38763422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis.
    Szekely T; Wichmann B; Maros ME; Csizmadia A; Bodor C; Timar B; Krenacs T
    Histopathology; 2023 Mar; 82(4):622-632. PubMed ID: 36416374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D Collagen Fiber Concentration Regulates Treg Cell Infiltration in Triple Negative Breast Cancer.
    Gao H; Tian Q; Zhou Y; Zhu L; Lu Y; Ma Y; Feng J; Jiang Y; Wang B
    Front Immunol; 2022; 13():904418. PubMed ID: 35774776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis of PD-L1 expression and prognosis in triple-negative breast cancers].
    Pan BJ; Xu C; Ping GQ; Song GX; Zhang WM; Wang C; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):822-826. PubMed ID: 29224274
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic value of tumour-stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review.
    Kramer CJH; Vangangelt KMH; van Pelt GW; Dekker TJA; Tollenaar RAEM; Mesker WE
    Breast Cancer Res Treat; 2019 Jan; 173(1):55-64. PubMed ID: 30302588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROGNOSTIC VALUE OF TUMOR STROMA RATIO IN TRIPLE NEGATIVE BREAST CANCER.
    Zakhartseva LM; Yanovytska MA
    Wiad Lek; 2021; 74(3 cz 2):565-571. PubMed ID: 33843614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma.
    Tavares MC; Sampaio CD; Lima GE; Andrade VP; Gonçalves DG; Macedo MP; Cordeiro de Lima VC
    BMC Cancer; 2021 Aug; 21(1):901. PubMed ID: 34362334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
    Wang Y; Brodsky AS; Xiong J; Lopresti ML; Yang D; Resnick MB
    Clin Breast Cancer; 2018 Jun; 18(3):e373-e379. PubMed ID: 28890185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human kallikrein 5 as a novel prognostic biomarker for triple-negative breast cancer: tissue expression analysis and relationship with disease course.
    Yang F; Li JY; Yin QN; Yang K; Dong SN; Bai LJ; Liu P; Tong XW
    Genet Mol Res; 2015 Aug; 14(3):9655-66. PubMed ID: 26345898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.